Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial

Published:2017-11-01 Issue:3 Volume:10 Page:256-265
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Mu Yiming¹,Liu Xiaomin²,Li Quanmin³,Chen Kangning⁴,Liu Yu⁵,Lv Xiaofeng⁶,Xu Xiangjin⁷,Fan Dongsheng⁸,Shang Ningxiu⁹,Yang Ruoyong¹⁰,Pauer Lynne¹¹,Pan Changyu¹

Affiliation:

1. Department of Endocrinology, Chinese PLA General Hospital; Beijing China

2. Department of Endocrinology, The First Affiliated Hospital; Harbin Medical University; Harbin China

3. Department of Endocrinology, The Second Artillery General Hospital of PLA; Beijing China

4. Department of Neurology, Southwest Hospital of Third Military Medical University; Chongqing China

5. Department of Endocrinology, The Second Hospital of Jilin University; Changchun China

6. Department of Endocrinology and Metabolism, General Hospital of Beijing Military Region; Beijing China

7. Department of Endocrinology, Fuzhou General Hospital of Nanjing Military Command; Nanjing China

8. Department of Neurology, Peking University Third Hospital; Beijing China

9. Global Product Development - Clinical Sciences & Operations - Development, Pfizer; Beijing China

10. Global Biometrics & Data Management - Statistics; Pfizer New York USA

11. Global Product Development - Clinical Sciences & Operations; Pfizer, Groton Connecticut USA

Funder

Pfizer

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1753-0407.12585/fullpdf

Reference41 articles.

1. The prevalance, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes;Davies;Diabetes Care,2006

2. The algorithm of diagnosis and treatment of diabetic peripheral neuropathy. Chinese endocrinologist association annual congress (CEAAC);Hu;Chin J Diabetes,2009

3. Prevalence and control of diabetes in Chinese adults;Xu;JAMA,2013

4. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep;Gore;J Pain Symptom Manage,2005

5. Painful diabetic neuropathy: A cross-sectional survey of health state impairment and treatment patterns;Tölle;J Diabetes Complications,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain;Pain and Therapy;2024-06-19

2. Neuropathic pain: Definition, classification and treatment;Galenika Medical Journal;2024

3. Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy;Diabetes & Metabolism Journal;2023-11-30

4. Placebo and nocebo responses in painful diabetic neuropathy: systematic review and meta-analysis;Pain;2023-08-02

5. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials;International Journal of Clinical Pharmacy;2023-02-27